Because the DNA binding domains of glucocorticoid receptor and androgen receptor are highly homologous and recognize identical DNA response elements, the glucocorticoid receptor can substitute for the androgen receptor to activate a subset of androgen receptor target genes which are required for prostate cancer survival and growth. The gene discussed is NR3C1; the disease is Familial prostate cancer.